---
figid: PMC8472484__biomedicines-09-01110-g009
figtitle: Ailanthoidol, a Neolignan, Suppresses TGFB1-Induced HepG2 Hepatoblastoma
  Cell Progression
organisms:
- NA
pmcid: PMC8472484
filename: biomedicines-09-01110-g009.jpg
figlink: /pmc/articles/PMC8472484/figure/biomedicines-09-01110-f009/
number: F9
caption: 'Effect of anti-tumor potential of Ailanthoidol (ATD), ATD blocks TGF-β1
  activated two signaling axes: P38MARK pathway and Smad 2/3 pathway, resulting in
  down-regulation of liver cancer progression associated proteins.'
papertitle: Ailanthoidol, a Neolignan, Suppresses TGF-β1-Induced HepG2 Hepatoblastoma
  Cell Progression.
reftext: Tsui-Hwa Tseng, et al. Biomedicines. 2021 Sep;9(9):1110.
year: '2021'
doi: 10.3390/biomedicines9091110
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: Ailanthoidol | TGF-β1 | p-38MAPK | anti-hepatic cancer progression
automl_pathway: 0.9406702
figid_alias: PMC8472484__F9
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8472484__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8472484__biomedicines-09-01110-g009.html
  '@type': Dataset
  description: 'Effect of anti-tumor potential of Ailanthoidol (ATD), ATD blocks TGF-β1
    activated two signaling axes: P38MARK pathway and Smad 2/3 pathway, resulting
    in down-regulation of liver cancer progression associated proteins.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATD
  - ATM
  - DTD2
  - TGFB1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - CDH2
  - MMP2
---
